Literature DB >> 6393684

Neurone loss in the nucleus basalis of Meynert in Creutzfeldt-Jakob disease.

T Arendt, V Bigl, A Arendt.   

Abstract

In a man of 47 with a 2-month history of Creutzfeldt-Jakob-disease verified neuropathologically a morphometric study of the nucleus basalis of Meynert, the major source of cholinergic innervation of the cortex, revealed a neuronal loss of 45%. The degeneration of these neurones may provide the morphological substrate of the cortical cholinergic deficiency which has been reported in this condition. The six subpopulations of the nucleus basalis were affected in different degrees. Neuronal loss was most pronounced in those subpopulations which project to cortical areas most affected by spongiosis and neuronal loss. It is suggested that maintenance of the nucleus basalis complex is a necessary condition for higher cortical function.

Entities:  

Mesh:

Year:  1984        PMID: 6393684     DOI: 10.1007/BF00689832

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  22 in total

1.  Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee.

Authors:  C J Gibbs; D C Gajdusek; D M Asher; M P Alpers; E Beck; P M Daniel; W B Matthews
Journal:  Science       Date:  1968-07-26       Impact factor: 47.728

2.  Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.

Authors:  R C Pearson; M V Sofroniew; A C Cuello; T P Powell; F Eckenstein; M M Esiri; G K Wilcock
Journal:  Brain Res       Date:  1983-12-19       Impact factor: 3.252

3.  Reduced cortical choline acetyltransferase activity in Gerstmann-Sträussler syndrome.

Authors:  Y Robitaille; P L Wood; P Etienne; S Lal; M H Finlayson; S Gauthier; N P Nair
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1982       Impact factor: 5.067

4.  Neuron loss in the nucleus basalis of Meynert in parkinsonism-dementia complex of Guam.

Authors:  I Nakano; A Hirano
Journal:  Ann Neurol       Date:  1983-01       Impact factor: 10.422

5.  Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.

Authors:  M M Mesulam; E J Mufson; A I Levey; B H Wainer
Journal:  J Comp Neurol       Date:  1983-02-20       Impact factor: 3.215

6.  Magnocellular nuclei of the basal forebrain project to neocortex, brain stem, and olfactory bulb. Review of some functional correlates.

Authors:  I Divac
Journal:  Brain Res       Date:  1975-08-15       Impact factor: 3.252

7.  Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

Authors:  J M Candy; R H Perry; E K Perry; D Irving; G Blessed; A F Fairbairn; B E Tomlinson
Journal:  J Neurol Sci       Date:  1983-05       Impact factor: 3.181

8.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

9.  Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy.

Authors:  F Tagliavini; G Pilleri; F Gemignani; A Lechi
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

10.  Basal forebrain neurons in the dementia of Parkinson disease.

Authors:  P J Whitehouse; J C Hedreen; C L White; D L Price
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

View more
  8 in total

1.  The nucleus basalis of Meynert in 20 definite cases of Creutzfeldt-Jakob disease.

Authors:  L Cartier; R Verdugo; C Vergara; S Galvez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

2.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.

Authors:  Haruo Hanyu; Tetsuichi Asano; Hirofumi Sakurai; Yuriko Tanaka; Masaru Takasaki; Kimihiko Abe
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

Review 3.  The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.

Authors:  R Schliebs; T Arendt
Journal:  J Neural Transm (Vienna)       Date:  2006-10-13       Impact factor: 3.575

4.  Pharmacogenetic regulation of acetylcholinesterase activity in Drosophila reveals the regulatory mechanisms of AChE inhibitors in synaptic plasticity.

Authors:  Wontae Kim; Daeweon Lee; Jinkyu Choi; Ayoung Kim; Sangmi Han; Kwanho Park; Jiyoung Choi; Jonggil Kim; Youngcheol Choi; Si Hyeock Lee; Young Ho Koh
Journal:  Neurochem Res       Date:  2011-02-09       Impact factor: 3.996

Review 5.  Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.

Authors:  Donald E Moss; Ruth G Perez
Journal:  Curr Alzheimer Res       Date:  2021       Impact factor: 3.498

Review 6.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

7.  Cholinergic control of visual categorization in macaques.

Authors:  Nikolaos C Aggelopoulos; Stefanie Liebe; Nikos K Logothetis; Gregor Rainer
Journal:  Front Behav Neurosci       Date:  2011-11-15       Impact factor: 3.558

Review 8.  Review: Revisiting the human cholinergic nucleus of the diagonal band of Broca.

Authors:  A K L Liu; E J Lim; I Ahmed; R C-C Chang; R K B Pearce; S M Gentleman
Journal:  Neuropathol Appl Neurobiol       Date:  2018-08-13       Impact factor: 8.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.